Published in Lancet on October 26, 1996
Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours. Br J Cancer (1998) 1.61
Artificial intelligence for clinicians. J R Soc Med (1999) 1.08
Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers (Basel) (2010) 1.04
The biological sense of cancer: a hypothesis. Theor Biol Med Model (2006) 0.81
Science versus quackery. J R Soc Med (1996) 0.75
Nonlinear analysis of biomagnetic signals recorded from uterine myomas. Biomagn Res Technol (2006) 0.75
Science versus quackery. J R Soc Med (1996) 0.75
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ (1990) 10.93
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J (Clin Res Ed) (1986) 5.37
Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet (1976) 4.53
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Psychological effects of being offered choice of surgery for breast cancer. BMJ (1994) 3.48
Do we need informed consent? Lancet (1986) 3.02
Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet (1998) 2.70
Breast cancer, desmoid tumours, and familial adenomatous polyposis--a unifying hypothesis. Lancet (1993) 2.69
Primary management of carcinoma of the breast. Lancet (1993) 2.59
Screening for breast cancer, time to think--and stop? Lancet (1995) 2.58
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol (1992) 2.45
Structural organization and functional analysis of centromeric DNA in the fission yeast Schizosaccharomyces pombe. Mol Cell Biol (1988) 2.37
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Clinical syndromes of mastalgia. Lancet (1976) 2.35
Mass screening for cancer of the breast. Lancet (1968) 2.33
Is clinical breast examination an acceptable alternative to mammographic screening? BMJ (2000) 2.18
Oestrogen as a reticuloendothelial stimulant in patients with cancer. Br Med J (1971) 2.14
Can results from clinical trials be generalized? Nat Med (1995) 2.13
Time to abandon TNM staging of breast cancer? Lancet (1992) 2.05
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell (1995) 1.99
HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem (1996) 1.87
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis (1996) 1.85
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. Ann Oncol (2006) 1.85
What are the psychological factors influencing attendance, non-attendance and re-attendance at a breast screening centre? J R Soc Med (1990) 1.83
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res (1992) 1.71
Organization of clinical trial on national scale: management of early cancer of the breast. Br Med J (1972) 1.70
Reticulo-endothelial activity in humans with cancer. Br J Surg (1970) 1.69
Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J (1994) 1.64
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. Lancet (1983) 1.61
Do psychological studies upset patients? J R Soc Med (1987) 1.60
Should lymphadenectomy be discarded? I. Immunological considerations. J R Coll Surg Edinb (1973) 1.60
Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ (1989) 1.59
The effects of surgery on tumor growth: a century of investigations. Ann Oncol (2008) 1.59
Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59
Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J (1967) 1.58
Effect of prenatal dexamethasone on rat renal development. Kidney Int (2001) 1.58
Contralateral renal abnormalities in multicystic-dysplastic kidney disease. J Pediatr (1992) 1.57
Putting the risk of breast cancer in perspective. BMJ (1998) 1.56
Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J (1977) 1.55
Tamoxifen and contralateral breast cancer. Lancet (1985) 1.53
False positive findings of mammography will have psychological consequences. BMJ (1996) 1.51
Does surgery disseminate or accelerate cancer? Lancet (1996) 1.50
Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) (1982) 1.49
The trials of Dr. Bernard Fisher: a European perspective on an American episode. Control Clin Trials (1997) 1.49
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer (1990) 1.48
The hypronosticon test in breast cancer. Clin Oncol (1975) 1.47
Addressing the psychological needs of the conservatively treated breast cancer patient: discussion paper. J R Soc Med (1987) 1.46
Rationalism versus irrationalism in the care of the sick: science versus the absurd. Med J Aust (1990) 1.46
Variations in gastric cancer mortality in South Wales. Clin Oncol (1979) 1.45
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS (2008) 1.42
A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer (1980) 1.42
The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res (1998) 1.41
Cognition and immune function in HIV-1 infection. AIDS (1992) 1.41
Further study into obstructive jaundice and ischaemic renal damage. Br Med J (1969) 1.41
Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest (1995) 1.41
Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol (2001) 1.39
Management of early carcinoma of the breast. Lancet (1972) 1.38
Breast cancer screening for younger women is not an efficient use of resources. BMJ (1997) 1.38
Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225). EMBO J (1992) 1.38
Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer. Lancet (1976) 1.38
Scientific empiricism and clinical medicine: a discussion paper. J R Soc Med (1981) 1.37
The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J Biol Chem (1998) 1.36
Replication of centromere II of Schizosaccharomyces pombe. Mol Cell Biol (1995) 1.35
Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol (1994) 1.33
Evidence for neutral transcellular NaCl transport and neutral basolateral chloride exit in the rabbit proximal convoluted tubule. J Clin Invest (1984) 1.32
Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest (1987) 1.32
High mutation rate and mutational bias at (TAA)n microsatellite loci in chickpea (Cicer arietinum L.). Mol Genet Genomics (2001) 1.32
Benign breast disease: the cost of the service and the cost to the patient. World J Surg (1990) 1.31
'Should a mammographic screening programme carry the warning: screening can damage your health!'? Br J Cancer (1999) 1.30
Structure and function of Schizosaccharomyces pombe centromeres. Cold Spring Harb Symp Quant Biol (1993) 1.30
Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg (1991) 1.29
The 'tru-cut' biopsy in breast cancer. Clin Oncol (1975) 1.29
Adjuvant treatment with tamoxifen. Side effects may have been overstated. BMJ (1996) 1.29
The operative management of subclinical breast cancer. Clin Oncol (1977) 1.27
Postoperative seroma following mastectomy and axillary dissection. Br J Surg (1987) 1.26
Carboxyl terminus of inducible nitric oxide synthase. Contribution to NADPH binding and enzymatic activity. J Biol Chem (1994) 1.26
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat (1994) 1.24
A genetic linkage map of Lens sp. based on microsatellite and AFLP markers and the localization of fusarium vascular wilt resistance. Theor Appl Genet (2005) 1.24
Psychological welfare of patients with breast cancer. J R Soc Med (1989) 1.23
pp60(c-src) is required for cell locomotion regulated by the hyaluronanreceptor RHAMM. Oncogene (1996) 1.21
Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg (2004) 1.21
Ventriculo-peritoneal shunt and breast carcinoma. Ann R Coll Surg Engl (2001) 1.20
Suction drainage of the axilla: a prospective randomized trial. Br J Surg (1988) 1.20
Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics (1993) 1.19
TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol (1993) 1.19
The curability of breast cancer. Br Med J (1976) 1.18
Comparison of flooding procedures in animals and man. Behav Res Ther (1971) 1.17
Evaluation of the MRL diagnostics dengue fever virus IgM capture ELISA and the PanBio Rapid Immunochromatographic Test for diagnosis of dengue fever in Jamaica. J Clin Microbiol (1999) 1.17
Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res (1985) 1.17
Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer? Surgery (1995) 1.17
Role of adenosine triphosphate (ATP) and NaK ATPase in the inhibition of proximal tubule transport with intracellular cystine loading. J Clin Invest (1991) 1.17
Cell surface glycosyltransferase activities. Int Rev Cytol (1980) 1.16
Novel amiloride-sensitive sodium-dependent proton secretion in the mouse proximal convoluted tubule. J Clin Invest (2000) 1.16
Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem (1993) 1.15
Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene (2006) 1.15
The retention and ultrastructural appearances of various extracellular matrix molecules incorporated into three-dimensional hydrated collagen lattices. Dev Biol (1985) 1.14